|Bid||1.78 x 1200|
|Ask||1.79 x 1800|
|Day's Range||1.7600 - 1.7900|
|52 Week Range||1.1300 - 4.5200|
|Beta (3Y Monthly)||1.13|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 28, 2017 - Jul 31, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.65|
BUENA, N.J., Jan. 02, 2019 -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the.
BUENA, N.J., Dec. 13, 2018 -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that on December 13, 2018 the Company entered into a definitive first.
NEW YORK, Dec. 03, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Teligent, Inc. (TLGT), on November 13, 2018 received a standard notice from NASDAQ stating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarterly period ended September 30, 2018, Teligent is not in compliance with NASDAQ Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission. As previously disclosed, additional time to file the Form 10-Q was required primarily due to the company’s transition to its newly engaged audit firm, as well as the need to amend its second quarter results. The company intends to file its Quarterly Reports with the SEC as soon as possible and continues to work diligently to finalize its financial statements.
On a per-share basis, the Buena, New Jersey-based company said it had a loss of 7 cents. Earnings, adjusted for non-recurring costs and stock option expense, came to less than 1 cent on a per-share basis. ...
BUENA, N.J., Nov. 13, 2018 -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that the Company secured a financing commitment from funds managed by.
BUENA, N.J., Nov. 12, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at.
Teligent (TLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BUENA, N.J., Oct. 24, 2018 -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the.
NEW YORK, Oct. 24, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
If you own shares in Teligent Inc (NASDAQ:TLGT) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of Read More...
TORONTO , Aug. 14, 2018 /CNW/ - Teligent, Inc. (TLGT) ("Teligent"), a specialty generic pharmaceutical company, averted a national sterile water and sodium chloride crisis by securing inventory to cover 100% of the Canadian Market following a breakdown in the global supply chain. The hurricanes that hit Puerto Rico this past fall damaged one of the largest sterile water and sodium chloride supplier's manufacturing plants, crippling supply and causing significant worldwide drug shortages. Sterile water and sodium chloride are essential components in the mixing of medications for injection.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 8) AstraZeneca plc (ADR) (NYSE: AZN ) Bio-Rad Laboratories, Inc. ...
Teligent (TLGT) delivered earnings and revenue surprises of -1900.00% and 4.34%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Buena, New Jersey-based company said it had a loss of 39 cents per share. Losses, adjusted to extinguish debt, were 20 cents per share. The specialty generic pharmaceutical company posted revenue of ...
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Teligent, Inc. (NASDAQ: TLGT ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 4:30:00 PM Eastern Time. ...